TNF and rheumatoid arthritis: For these reasons, TNF-α has been extensively identified as a therapeutic target, leading to the development of several TNF inhibitors that actually represent the mainstay of treatment of moderate-severe disease modifying anti-rheumatic drugs (DMARDs) refractory RA [31].